Author

Naiara Santana-Codina

Aarhus UniversityORCID 0000-0002-8250-4530Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Marina CiscariD· 2 shared Abhimanyu DasGupta· 1 shared Alberto DelaidelliiD· 1 shared Andrew J. AguirreiD· 1 shared Aparna PadhyeiD· 1 shared Aslihan YavasiD· 1 shared Bin Yu· 1 shared César Rodríguez-SantanaiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Marina CiscarORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GALE-dependent glycoproteome remodelling is a determinant of oncogenic RAS transformation

Frauke Stölting, Rita Vesce, César Rodríguez-Santana, Marina Ciscar, Alberto Delaidelli, Qiaochu Lin, Christian Ballmeyer, Sophie Chan, Ramona Lesch, Ruitong Li, Abhimanyu DasGupta, Bin Yu, Daniel Picard, Vithusan Suppiyar, Francesco Casini, , Jonathan K. M. Lim

This study identifies GALE as a key regulator of glycoproteome remodelling in RAS-driven cancer, showing its role in sialylation and tumorigenicity.

bioRxiv · Jun 23, 2026 · PreprintCancer Biology

De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer

Huan Zhang, Naiara Santana-Codina, Qijia Yu, Clara L. Poupault, Claudia Campos, Xingping Qin, Nicole Sindoni, Marina Ciscar, Aparna Padhye, Miljan Kuljanin, Junning Wang, Matthew J. Dorman, Peter Bross, Andrew J. Aguirre, Stephanie K. Dougan, , Joseph Douglas Mancias

This study identifies that combining DHODH inhibition with BCL-XL targeting synergistically induces apoptosis in pancreatic cancer, offering a new combination therapy strategy.

Nature Communications · Jul 30, 2025Peer-reviewedCancer Biology